v

Biogen to develop zinc finger therapies with Sangamo




v

First in vivo CRISPR gene editing in humans




v

Ingevity CEO Wilson resigns unexpectedly




v

Calysta and Adisseo plan fish feed venture in Asia




v

Orionis Biosciences launches with Novartis pact




v

South Korean joint venture to make hydrogen peroxide from steel byproduct




v

Scientists' favorite DIY lab equipment, and making lab trash live on




v

Actinide orbitals drive C–C coupling

Reaction creates actinide 2-metallabiphenylenes




v

How to answer difficult interview questions




v

Photocatalyst converts fatty acids to diesel and jet-fuel molecules selectively

Method provides petroleum-free way to turn industrial biowaste into valuable commodity




v

How to make aziridines from olefins without expensive metals

Double bonds form nitrogen-containing 3-membered rings thanks to a reactive yet fleeting oxaziridine intermediate




v

A full simulation of H1N1 flu virus

160-million-atom simulation reveals potential drug targets




v

Amy Ripka on being a CEO: ‘Nobody ever got anywhere by listening to no'

Lucy Therapeutics founder is taking an atypical approach to finding drugs for central nervous system diseases




v

Sarah Richardson on prestige publishing: ‘Luckily, I don't give a crap about that'

Her company, MicroByre, is proving that wild microbes can be engineered to produce useful chemicals




v

Olga Malinkiewicz wants to make good on the promise of perovskites

Her company, Saule Technologies, has a low-cost process to print the solar cells on a multitude of materials




v

Yamuna Krishnan's goal: Find drugs for neurodegenerative diseases

Her company, Esya Labs, is developing DNA nanodevices that track drug responses, screen for new therapies, and more




v

Samantha Du builds biotechs, and everyone in China follows

Known as Big Sister for her mentorship, Du and her newest firm, Zai Lab, are setting new standards in Asia




v

CRISPR technology: Where female entrepreneurs thrive

Dozens of women lead CRISPR-based projects worldwide. Here are a few who've built start-ups around the technology




v

Gilead y Moderna lideran los tratamientos contra el coronavirus

Gilead toma ventaja gracias a un antiviral, mientras que Moderna está buscando una nueva vacuna ARNm.




v

Chemists work around coronavirus restrictions

C&EN looks at how scientists are adapting to travel restrictions and working from home




v

Coronavirus forces cancellations of scientific meetings

Spring lineup of conferences and events frequented by chemists is slashed




v

Podcast: How the coronavirus could disrupt the drug supply

Hear what C&EN's pharmaceutical editors have learned about how the coronavirus is affecting drug production in China and across the globe




v

One-pot process converts CO<sub>2</sub> captured from the air into methanol

Scientists use an alkali hydroxide–based system to turn carbon dioxide into a carbon-neutral fuel




v

Celgard sues Chinese firm over battery technology

Complaint alleges trade secret theft, patent infringement on separator films




v

Merck and Princeton scientists create method to map cell-surface microenvironments

The technique, called MicroMapping, identifies potential protein interactions on and between cells




v

Coronavirus hits Europe

Chemical makers brace for a slowdown on the continent




v

Can old drugs take down a new coronavirus?

Several approved and well-studied small molecules could be repurposed as treatments for COVID-19




v

Chemistry in Pictures: Be still, my giant rotovap




v

EPA overhauls pesticide biological evaluations

Agency's approach for assessing risks to endangered species relies on real-world data




v

How COVID-19 is changing my graduate school experience




v

How we know disinfectants should kill the COVID-19 coronavirus

The novel virus is one of the easiest virus types to deactivate, though SARS-CoV-2–specific data are lacking




v

Bryan Brooks named editor in chief of <i>Environmental Science and Technology Letters</i>




v

Genentech Foundation provides $3 million grant to ACS Bridge Project




v

Culture Biosciences raises $15 million for bioreactor service




v

Gates, Wellcome, and Mastercard give $125 million for coronavirus treatments




v

Asahi Kasei to buy automotive upholstery fabric maker Adient




v

Neste invests in plastic recycling and hydrogen firms




v

OMV to raise stake in Borealis




v

$8.3 billion allocated for US coronavirus response

Congress opts for open-ended support for federal and local agencies




v

Chemists work around coronavirus restrictions

C&EN looks at how scientists are working from home and adapting to travel restrictions




v

Researchers in China report structure of the novel coronavirus bound to its human target

The structure shows the first steps of SARS-CoV-2 infection and could help in drug discovery




v

Dishing on dishwashing for a greener planet and playing games in a glove box




v

Mechanical chirality gives new shape to catalysis

Mechanically chiral rotaxane creates a catalytic pocket a little like an enzyme




v

As telecom demands grow, optical fibers will need to level up

Scientists explore how to revamp the hair-thin silica glass fibers to transmit more and more data




v

Carolyn Bertozzi awarded 2020 Solvay Prize

Stanford professor honored for her invention of bioorthogonal chemistry




v

How small chemical company leaders are dealing with the coronavirus

Specialty chemical CEOs are rolling with the punches to keep their firms going




v

Leaks of CFCs threaten ozone layer recovery and climate, researchers say

Aging equipment and plastic foam release chemicals




v

Air quality improvements boosted California's agriculture industry

Lower ozone levels led to higher grape and almond yields-and decarbonizing the state's economy could provide a further boost




v

COVID-19 coronavirus weighs on economy, chemicals

Chemical makers and oil producers are pulling back on production, reconsidering investments




v

BioNTech joins coronavirus vaccine race

The German firm will work with Fosun Pharma and Pfizer to develop an mRNA vaccine for COVID-19